Positive Outlook on Veeva Systems: Buy Rating Backed by CRM Transition and R&D Growth Potential
Needham analyst Ryan MacDonald maintained a Buy rating on Veeva Systems (VEEV – Research Report) today and set a price target of $270.00.Stay ...
Global Pharma & Biotech CRM Software Market To Surpass Valuation of US$ 20.0 Billion by 2033 | Astute Analytica
Rapid advancements in technology and heightened regulatory requirements are propelling growth in the pharma and biotech CRM ...
pharmaphorum14h
Four key trends and innovations catalysing infusion therapy as we enter 2025
The establishment of the ERAS protocols catalyses the changes in the IV treatment settings and highlights the need for a ...
pharmaphorum11h
Tackling inappropriate prescription practices for weight loss drugs
Mounjaro, like other GLP-1 drugs, carries potential side effects, including nausea, vomiting, dehydration, and hypoglycaemia ...